The activity of SOD in the brains of APP/PS1 transgenic mice was significantly decreased, indicating decreased antioxidant capacity, and which was consistent with the clinical lesions of aging and senile patients with cognitive impairment. The gene discussed is SOD1; the disease is Cognitive impairment.